iTeos Therapeutics Inc Sustainability Reports

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of a new generation of immuno-oncology therapeutics for cancer patients.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG00VPNFT94

4 reports from 2021 to 2023

• iTeos Therapeutics Inc 2023 Environmental, Social and Governance Report
• iTeos Therapeutics Inc 2022 Form 10-K
• iTeos Therapeutics Inc 2022 Environmental, Social and Governance Report
• iTeos Therapeutics Inc 2021 Form 10-K